Lifecode

The deal, which comes about three months after Lifecode's acquisition by MedGenome, marks Vela's first foray into the genomic data interpretation market.

The acquisition will give India's MedGenome access to a CLIA-certified and CAP-accredited laboratory in the Bay Area so that it can expand its operations in the US.

The previously undisclosed Series A Round financing was led by Sequoia Capital, Mayo Clinic, and Mayo Ventures. 

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

In Science this week: the synthetic genetic system hachimoji, and more.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.